261 related articles for article (PubMed ID: 21225228)
1. Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2.
Singh T; Katiyar SK
Int J Oncol; 2011 Mar; 38(3):769-76. PubMed ID: 21225228
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
4. Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation.
Vaid M; Sharma SD; Katiyar SK
Carcinogenesis; 2010 Nov; 31(11):2004-11. PubMed ID: 20823108
[TBL] [Abstract][Full Text] [Related]
5. Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE₂-mediated activation of β-catenin signaling.
Singh T; Katiyar SK
PLoS One; 2013; 8(4):e60749. PubMed ID: 23580348
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effect of 4-O-methylhonokiol, compound isolated from Magnolia officinalis through inhibition of NF-kappaB [corrected].
Oh JH; Kang LL; Ban JO; Kim YH; Kim KH; Han SB; Hong JT
Chem Biol Interact; 2009 Aug; 180(3):506-14. PubMed ID: 19539808
[TBL] [Abstract][Full Text] [Related]
7. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
Hahm ER; Arlotti JA; Marynowski SW; Singh SV
Clin Cancer Res; 2008 Feb; 14(4):1248-57. PubMed ID: 18281560
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of non-small cell lung cancer cell migration by grape seed proanthocyanidins is mediated through the inhibition of nitric oxide, guanylate cyclase, and ERK1/2.
Punathil T; Katiyar SK
Mol Carcinog; 2009 Mar; 48(3):232-242. PubMed ID: 18680102
[TBL] [Abstract][Full Text] [Related]
9. Honokiol stimulates osteoblastogenesis by suppressing NF-κB activation.
Yamaguchi M; Arbiser JL; Weitzmann MN
Int J Mol Med; 2011 Dec; 28(6):1049-53. PubMed ID: 21887456
[TBL] [Abstract][Full Text] [Related]
10. Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells.
Hua H; Chen W; Shen L; Sheng Q; Teng L
Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):773-9. PubMed ID: 23786838
[TBL] [Abstract][Full Text] [Related]
11. Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes.
Chen YJ; Tsai KS; Chan DC; Lan KC; Chen CF; Yang RS; Liu SH
J Orthop Res; 2014 Apr; 32(4):573-80. PubMed ID: 24375705
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol.
Xu D; Lu Q; Hu X
Cancer Lett; 2006 Nov; 243(2):274-80. PubMed ID: 16406853
[TBL] [Abstract][Full Text] [Related]
13. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
14. Honokiol protects rats against eccentric exercise-induced skeletal muscle damage by inhibiting NF-kappaB induced oxidative stress and inflammation.
Chiang J; Shen YC; Wang YH; Hou YC; Chen CC; Liao JF; Yu MC; Juan CW; Liou KT
Eur J Pharmacol; 2009 May; 610(1-3):119-27. PubMed ID: 19303869
[TBL] [Abstract][Full Text] [Related]
15. Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress.
Chen YJ; Wu CL; Liu JF; Fong YC; Hsu SF; Li TM; Su YC; Liu SH; Tang CH
Cancer Lett; 2010 May; 291(1):20-30. PubMed ID: 19880244
[TBL] [Abstract][Full Text] [Related]
16. Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin.
Hu H; Zhang XX; Wang YY; Chen SZ
Acta Pharmacol Sin; 2005 Sep; 26(9):1063-8. PubMed ID: 16115372
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents.
Xu Q; Yi LT; Pan Y; Wang X; Li YC; Li JM; Wang CP; Kong LD
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):715-25. PubMed ID: 18093712
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase.
Jadeski LC; Chakraborty C; Lala PK
Int J Cancer; 2003 Sep; 106(4):496-504. PubMed ID: 12845643
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of honokiol on lipopolysaccharide-induced cellular responses and signaling events in human renal mesangial cells.
Wu F; Zhang W; Li L; Zheng F; Shao X; Zhou J; Li H
Eur J Pharmacol; 2011 Mar; 654(1):117-21. PubMed ID: 21147091
[TBL] [Abstract][Full Text] [Related]
20. Honokiol up-regulates prostacyclin synthease protein expression and inhibits endothelial cell apoptosis.
Zhang X; Chen S; Wang Y
Eur J Pharmacol; 2007 Jan; 554(1):1-7. PubMed ID: 17109844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]